Search results
Results From The WOW.Com Content Network
The provision concerns so-called qui tam actions, in which private litigants bring lawsuits on behalf of the government as well as themselves. (The Latin term came to us via old English law.)
Relator Stevens, a former employee of the Vermont Agency of Natural Resources, brought a qui tam civil action against the agency, alleging that the state agency had submitted false claims to the U.S. Environmental Protection Agency (EPA) in connection with federal grant programs the EPA administered.
The historical antecedents of qui tam statutes lie in Roman and Anglo-Saxon law. [3] Roman criminal prosecutions were typically initiated by private citizens and beginning no later than the Lex Pedia, it became common for Roman criminal statutes to offer a portion of the defendant's forfeited property to the initiator of the prosecution as a reward. [3]
A qui tam (in the name of the king) action may be brought by any party (as a relator) against an entity that is fraudulently collecting money from the United States government by filing false claims. The party bringing the suit – the relator – must have possession of information substantiating the claim of fraud against the government.
A Trenton federal judge has dismissed a False Claims Act suit against Sanofi and Bristol-Myers Squibb over anti-blood clot drug Plavix, citing a change in the composition of the partnership that ...
intervene in one or more counts of the pending qui tam action. This intervention expresses the Government's intention to participate as a plaintiff in prosecuting that count of the complaint. The department intervenes in fewer than 25% of filed qui tam actions. decline to intervene in one or all counts of the pending qui tam action. If the ...
qui tam pro domino rege quam pro se ipso in hac parte sequitur he who brings an action for the king as well as for himself Generally known as 'qui tam,' it is the technical legal term for the unique mechanism in the federal False Claims Act that allows persons and entities with evidence of fraud against federal programs or contracts to sue the ...
After a month, relator Glenn Grossenbacher, an attorney, filed a second qui tam action against GlaxoSmithKline in the United States District Court for the Western District of Texas. Relators Kevin Spear, Jack Dowden, and the Berkeley Community Law Center (collectively, "the Spear relators") followed in February 1995 with a suit in the Northern ...